{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:39Z","timestamp":1791357339689,"version":"4.3.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T00:00:00Z","timestamp":1369699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11920-013-0371-6","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T18:52:18Z","timestamp":1369680738000},"source":"Crossref","is-referenced-by-count":137,"title":["Enhancing ADHD Medication Adherence: Challenges and Opportunities"],"prefix":"10.1007","volume":"15","author":[{"given":"Alice","family":"Charach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,28]]},"reference":[{"key":"371_CR1","unstructured":"Charach A, Dashti B, Carson P, Booker L, Lim CG, Lillie E, et al. Attention deficit hyperactivity disorder: effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. Rockville (MD): Agency for healthcare research and quality (US); 2011. Report No.: 12-EHC003-EF."},{"issue":"4","key":"371_CR2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/CHI.0b013e31816429d3","volume":"47","author":"J Biederman","year":"2008","unstructured":"Biederman J et al. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry. 2008;47(4):426\u201334.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"371_CR3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/DBP.0b013e3180327917","volume":"28","author":"J Biederman","year":"2007","unstructured":"Biederman J et al. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr. 2007;28(4):302\u20137.","journal-title":"J Dev Behav Pediatr"},{"issue":"2","key":"371_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.chi.0000189134.97436.e2","volume":"45","author":"RA Barkley","year":"2006","unstructured":"Barkley RA et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatr. 2006;45(2):192\u2013202.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"3","key":"371_CR5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.aap.2009.06.021","volume":"42","author":"B Reimer","year":"2010","unstructured":"Reimer B et al. The impact of distractions on young driverswith attention deficit hyperactivity disorder (ADHD). Accid Anal Prev. 2010;42(3):842\u201351.","journal-title":"Accid Anal Prev"},{"issue":"2","key":"371_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10899-010-9211-3","volume":"27","author":"N Faregh","year":"2011","unstructured":"Faregh N, Derevensky J. Gambling behavior among adolescents with attention deficit\/hyperactivity disorder. J Gambl Stud. 2011;27(2):243\u201356.","journal-title":"J Gambl Stud"},{"issue":"5","key":"371_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11920-008-0068-4","volume":"10","author":"DW Murray","year":"2008","unstructured":"Murray DW et al. A clinical review of outcomes of the multimodal treatment study of children with attention-deficit\/hyperactivity disorder (MTA). Curr Psychiatry Rep. 2008;10(5):424\u201331.","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"371_CR8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DBP.0b013e3180cabc28","volume":"28","author":"WJ Barbaresi","year":"2007","unstructured":"Barbaresi WJ, Katusic SK, Colligan RC. Modifiers of long-term school outcomes for children with attention-deficit\/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007;28(4):274\u201387.","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"371_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1542\/peds.2008-3347","volume":"124","author":"J Biederman","year":"2009","unstructured":"Biederman J et al. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009;124(1):71\u20138.","journal-title":"Pediatrics"},{"issue":"10","key":"371_CR10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archpedi.162.10.916","volume":"162","author":"TE Wilens","year":"2008","unstructured":"Wilens TE et al. Effect of prior stimulant treatment for attention-deficit\/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916\u201321.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"21","key":"371_CR11","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1203241","volume":"367","author":"P Lichtenstein","year":"2012","unstructured":"Lichtenstein P et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2012;367(21):2006\u201314.","journal-title":"N Engl J Med"},{"issue":"10","key":"371_CR12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1586\/14737175.8.10.1563","volume":"8","author":"A Charach","year":"2008","unstructured":"Charach A, Gajaria A. Improving psychostimulant adherence in children with ADHD. Expert Rev Neurother. 2008;8(10):1563\u201371.","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"371_CR13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00004583-200405000-00009","volume":"43","author":"A Charach","year":"2004","unstructured":"Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatr. 2004;43(5):559\u201367.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"key":"371_CR14","doi-asserted-by":"crossref","unstructured":"The MTA cooperative group. A 14 month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073\u20131086.","DOI":"10.1001\/archpsyc.56.12.1073"},{"issue":"2 Suppl","key":"371_CR15","first-page":"26S","volume":"41","author":"AACAP","year":"2002","unstructured":"AACAP. Practice, parameter for the use of stimulant medications in the treatment of children, adolescents and adults. J Am Acad Child Adolesc. 2002;41(2 Suppl):26S\u201349.","journal-title":"J Am Acad Child Adolesc"},{"issue":"4","key":"371_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1744-6155.2006.00063.x","volume":"11","author":"JB Meaux","year":"2006","unstructured":"Meaux JB et al. Stimulant medications: a trade-off? The lived experience of adolescents with ADHD. J Spec Pediatr Nurs. 2006;11(4):214\u201326.","journal-title":"J Spec Pediatr Nurs"},{"issue":"1","key":"371_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004703-200602000-00001","volume":"27","author":"WJ Barbaresi","year":"2006","unstructured":"Barbaresi WJ et al. Long-term stimulant medication treatment of attention-deficit\/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006;27(1):1\u201310.","journal-title":"J Dev Behav Pediatr"},{"issue":"7","key":"371_CR18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00004583-199707000-00012","volume":"36","author":"DR Hirshfeld","year":"1997","unstructured":"Hirshfeld DR et al. Expressed emotion toward children with behavioral inhibition: associations with maternal anxiety disorder. J Am Acad Child Adolesc Psychiatr. 1997;36(7):910\u20137.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"1","key":"371_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-3-1","volume":"3","author":"E Parens","year":"2009","unstructured":"Parens E, Johnston J. Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies. Child Adolesc Psychiatr Ment Health. 2009;3(1):1.","journal-title":"Child Adolesc Psychiatr Ment Health"},{"issue":"5","key":"371_CR20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1469-7610.2005.01590.x","volume":"47","author":"BB Lahey","year":"2006","unstructured":"Lahey BB et al. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit\/hyperactivity disorder among younger children. J Child Psychol Psychiatry. 2006;47(5):472\u20139.","journal-title":"J Child Psychol Psychiatry"},{"issue":"239","key":"371_CR21","first-page":"1","volume":"10","author":"B Bloom","year":"2009","unstructured":"Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2007. Vital Health Stat. 2009;10(239):1\u201380.","journal-title":"Vital Health Stat"},{"issue":"11","key":"371_CR22","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/MLR.0b013e31806728fa","volume":"45","author":"JL Hudson","year":"2007","unstructured":"Hudson JL, Miller GE, Kirby JB. Explaining racial and ethnic differences in children's use of stimulant medications. Med Care. 2007;45(11):1068\u201375.","journal-title":"Med Care"},{"issue":"5","key":"371_CR23","first-page":"472","volume":"47","author":"J Williams","year":"2006","unstructured":"Williams J, Taylor E. The evolution of hyperactivity, impulsivity and cognitive diversity. J R Soc Interface. 2006;47(5):472\u20139.","journal-title":"J R Soc Interface"},{"issue":"1","key":"371_CR24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/cap.2005.15.88","volume":"15","author":"J Stevens","year":"2005","unstructured":"Stevens J, Harman JS, Kelleher KJ. Race\/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol. 2005;15(1):88\u201396.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"371_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/cap.2006.16.441","volume":"16","author":"SS Gau","year":"2006","unstructured":"Gau SS et al. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit\/hyperactivity disorder in Taiwan. J Child Adolesc Psychopharmacol. 2006;16(4):441\u201355.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"371_CR26","first-page":"e50","volume":"13","author":"M Steele","year":"2006","unstructured":"Steele M et al. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006;13(1):e50\u201362.","journal-title":"Can J Clin Pharmacol"},{"issue":"2","key":"371_CR27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/cap.2008.096","volume":"19","author":"CY Chen","year":"2009","unstructured":"Chen CY, Gerhard T, Winterstein AG. Determinants of initial pharmacological treatment for youths with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19(2):187\u201395.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"371_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CHI.0b013e31818b1c8f","volume":"48","author":"M Olfson","year":"2009","unstructured":"Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Adolesc Psychiatr. 2009;48(1):51\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"11","key":"371_CR29","first-page":"1489","volume":"165","author":"AR Miller","year":"2001","unstructured":"Miller AR et al. Prescription of methylphenidate to children and youth, 1990-1996. CMAJ. 2001;165(11):1489\u201394.","journal-title":"CMAJ"},{"issue":"6","key":"371_CR30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpedi.159.6.572","volume":"159","author":"SC Marcus","year":"2005","unstructured":"Marcus SC et al. Continuity of methylphenidate treatment for attention-deficit\/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159(6):572\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"371_CR31","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/chi.0b013e31806ad1d7","volume":"46","author":"SV Faraone","year":"2007","unstructured":"Faraone SV, Giefer EE. Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth. J Am Acad Child Adolesc Psychiatr. 2007;46(9):1138\u201347.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"4","key":"371_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10673229.2011.602560","volume":"19","author":"RE Gearing","year":"2011","unstructured":"\u2022 Gearing RE et al. Reconceptualizing medication adherence: six phases of dynamic adherence. Harv Rev Psychiatr. 2011;19(4):177\u201389. This article describes a six-phase model of transactional processes and other factors that influence patients' medication adherence decisions, placing the patient\u2013provider relationship as central to the process.","journal-title":"Harv Rev Psychiatr"},{"issue":"1","key":"371_CR33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.socscimed.2011.10.009","volume":"74","author":"R Bussing","year":"2012","unstructured":"\u2022\u2022 Bussing R et al. Willingness to use ADHD treatments: a mixed methods study of perceptions by adolescents, parents, health professionals and teachers. Soc Sci Med. 2012;74(1):92\u2013100. This study describes overall perceptions of relative burden of several commonly used interventions (medication, behavior therapy, psychoeducation, counseling) for ADHD.","journal-title":"Soc Sci Med"},{"issue":"2","key":"371_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/09540260801933084","volume":"20","author":"S DosReis","year":"2008","unstructured":"DosReis S et al. Parental attitudes in psychopharmacological treatment for ADHD: a conceptual model. Int Rev Psychiatr. 2008;20(2):135\u201341.","journal-title":"Int Rev Psychiatr"},{"issue":"4","key":"371_CR35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/cap.2008.0118","volume":"19","author":"S DosReis","year":"2009","unstructured":"DosReis S et al. The meaning of attention-deficit\/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child. J Child Adolesc Psychopharmacol. 2009;19(4):377\u201383.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"371_CR36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10673220127905","volume":"9","author":"R Bussing","year":"2001","unstructured":"Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: friends or foes? Harv Rev Psychiatr. 2001;9(5):223\u201333.","journal-title":"Harv Rev Psychiatr"},{"issue":"1","key":"371_CR37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.beth.2007.04.002","volume":"39","author":"C Johnston","year":"2008","unstructured":"Johnston C, Hommersen P, Seipp C. Acceptability of behavioral and pharmacological treatments for attention-deficit\/hyperactivity disorder: relations to child and parent characteristics. Behav Ther. 2008;39(1):22\u201332.","journal-title":"Behav Ther"},{"issue":"3","key":"371_CR38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/cap.2011.0090","volume":"22","author":"DJ Coletti","year":"2012","unstructured":"Coletti DJ et al. Parent perspectives on the decision to initiate medication treatment of attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012;22(3):226\u201337.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"10","key":"371_CR39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/070674379904401011","volume":"44","author":"P Corkum","year":"1999","unstructured":"Corkum P, Rimer P, Shachar R. Parental knowledge of attention-deficit\/hyperactivity disorder and opinions of treatment option: impact on enrollment and adherence to a 12-month treatment trial. Can J Psychiatr Rev Canad Psychiatr. 1999;44(10):1043\u20138.","journal-title":"Can J Psychiatr Rev Canad Psychiatr"},{"issue":"3","key":"371_CR40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/cap.2006.16.286","volume":"16","author":"SS Gau","year":"2006","unstructured":"Gau SS et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol. 2006;16(3):286\u201397.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"371_CR41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00012272-200304000-00004","volume":"26","author":"J Kendall","year":"2003","unstructured":"Kendall J et al. Children's Accounts of attention-deficit\/hyperactivity disorder. ANS Adv Nurs Sci. 2003;26(2):114\u201330.","journal-title":"ANS Adv Nurs Sci"},{"issue":"4","key":"371_CR42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1475-3588.2010.00565.x","volume":"15","author":"I Singh","year":"2010","unstructured":"Singh I, Kendall T, Taylor C. Young People\u2019s experience of ADHD and stimulant medication: a qualitative study for the NICE guideline. Child Adolesc Ment Health. 2010;15(4):186\u201392.","journal-title":"Child Adolesc Ment Health"},{"issue":"8","key":"371_CR43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/0009922812446744","volume":"51","author":"SL Toomey","year":"2012","unstructured":"Toomey SL et al. Why do children with ADHD discontinue their medication? Clin Pediatr (Phila). 2012;51(8):763\u20139.","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"371_CR44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jadohealth.2010.08.014","volume":"49","author":"R Bussing","year":"2011","unstructured":"\u2022\u2022 Bussing R et al. Receiving treatment for attention-deficit hyperactivity disorder: do the perspectives of adolescents matter? J Adolesc Health. 2011;49(1):7\u201314. This study documents differences and factors contributing to those differences between adolescent and parent perspectives on receiving treatment for ADHD.","journal-title":"J Adolesc Health"},{"key":"371_CR45","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1542\/peds.2010-1510","volume":"127","author":"G Fiks","year":"2011","unstructured":"Fiks G, Hughes C, Gafen A. Contrasting parents\u2019 and pediatricians\u2019 perspectives on shared-decision making in ADHD. Pediatrics. 2011;127:e188\u201396.","journal-title":"Pediatrics"},{"issue":"1","key":"371_CR46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1542\/peds.2011-1352","volume":"129","author":"AG Fiks","year":"2012","unstructured":"Fiks AG et al. Shared decision-making and health care expenditures among children with special health care needs. Pediatrics. 2012;129(1):99\u2013107.","journal-title":"Pediatrics"},{"issue":"2","key":"371_CR47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1542\/peds.2010-0526","volume":"126","author":"AG Fiks","year":"2010","unstructured":"Fiks AG et al. Shared decision-making in pediatrics: a national perspective. Pediatrics. 2010;126(2):306\u201314.","journal-title":"Pediatrics"},{"issue":"6","key":"371_CR48","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","volume":"165","author":"JH Newcorn","year":"2008","unstructured":"Newcorn JH et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry. 2008;165(6):721\u201330.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"371_CR49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/cap.2007.0068","volume":"17","author":"HB Abikoff","year":"2007","unstructured":"Abikoff HB et al. Methylphenidate effects on functional outcomes in the preschoolers with attention-deficit\/hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmacol. 2007;17(5):581\u201392.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"371_CR50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1542\/peds.2008-0185","volume":"123","author":"AD Mosholder","year":"2009","unstructured":"Mosholder AD et al. Hallucinations and other psychotic symptoms associated with the use of attention-deficit\/hyperactivity disorder drugs in children. Pediatrics. 2009;123(2):611\u20136.","journal-title":"Pediatrics"},{"issue":"2","key":"371_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/chi.0b013e31815d88b2","volume":"47","author":"ME Bangs","year":"2008","unstructured":"Bangs ME et al. Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatr. 2008;47(2):209\u201318.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"key":"371_CR52","doi-asserted-by":"crossref","unstructured":"Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention\u2010deficit\/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007\u201322.","DOI":"10.1542\/peds.2011-2654"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-013-0371-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-013-0371-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-013-0371-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T05:11:59Z","timestamp":1563081119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-013-0371-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,28]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1007\/s11920-013-0371-6","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,28]]},"article-number":"371"}}